Literature DB >> 6733684

Follicular neoplasms of the thyroid. A study of 44 cases followed for a minimum of 10 years, with emphasis on differential diagnosis.

H L Evans.   

Abstract

Forty-four follicular thyroid neoplasms followed for a minimum of 10 years are presented. The cases were divided into four categories: follicular adenoma (19 cases), encapsulated follicular carcinoma (7 cases), invasive follicular carcinoma (11 cases), and the follicular variant of papillary carcinoma (7 cases). The former two tumor types were distinguished by the presence of capsular invasion in encapsulated follicular carcinoma (which was defined as lacking extension into the surrounding thyroid) and by the frequent thinness of the capsule in follicular adenoma, while the latter two (which both infiltrated adjacent thyroid or extrathyroid tissue) were separated primarily on the basis of the tendency toward vesicular and hypochromatic nuclear staining in the follicular variant of papillary carcinoma, but with consideration of a number of other factors in addition. No patient with follicular adenoma had any further difficulty after removal of the lesion. Metastasis to cervical lymph nodes occurred in five cases of the follicular variant of papillary carcinoma, but there were no distant metastases or deaths due to tumor. By contrast, three patients with encapsulated follicular carcinoma and nine with invasive follicular carcinoma died of tumor, and all of these had distant metastasis (most often to bone). Local recurrence was seen only in invasive follicular carcinoma (six cases).

Entities:  

Mesh:

Substances:

Year:  1984        PMID: 6733684     DOI: 10.1002/1097-0142(19840801)54:3<535::aid-cncr2820540325>3.0.co;2-t

Source DB:  PubMed          Journal:  Cancer        ISSN: 0008-543X            Impact factor:   6.860


  14 in total

Review 1.  Follicular-patterned tumors of the thyroid: the battle of benign vs. malignant vs. so-called uncertain.

Authors:  Virginia A LiVolsi; Zubair W Baloch
Journal:  Endocr Pathol       Date:  2011-12       Impact factor: 3.943

Review 2.  Our approach to follicular-patterned lesions of the thyroid.

Authors:  Zubair W Baloch; Virginia A LiVolsi
Journal:  J Clin Pathol       Date:  2006-06-23       Impact factor: 3.411

Review 3.  Handling of thyroid follicular patterned lesions.

Authors:  Juan Rosai
Journal:  Endocr Pathol       Date:  2005       Impact factor: 3.943

4.  When is total thyroidectomy indicated as a treatment of "follicular carcinoma"?

Authors:  T Yamashita; Y Fujimoto; T Kodama; A Hirayama; T Obara; Y Ito; M Aiba; K Kusakabe
Journal:  World J Surg       Date:  1988-08       Impact factor: 3.352

5.  Follicular thyroid tumours: a study of laminin and type IV collagen in basement membrane and endothelium.

Authors:  C H Kendall; P R Sanderson; J Cope; I C Talbot
Journal:  J Clin Pathol       Date:  1985-10       Impact factor: 3.411

6.  Postoperative ultrasonography surveillance in patients with follicular thyroid carcinoma: a multicenter study.

Authors:  Hye Jin Baek; Dong Wook Kim; Song Lee; Inseon Ryoo; Chang Yoon Lee; Yoon Jung Choi; Jin Yong Sung
Journal:  Radiol Med       Date:  2017-03-14       Impact factor: 3.469

Review 7.  Follicular-patterned afflictions of the thyroid gland: reappraisal of the most discussed entity in endocrine pathology.

Authors:  Zubair W Baloch; Virginia A LiVolsi
Journal:  Endocr Pathol       Date:  2014-03       Impact factor: 3.943

8.  Diagnostic and prognostic utility of flow cytometric DNA measurements in follicular thyroid tumors.

Authors:  C S Grant; I D Hay; J J Ryan; E J Bergstralh; L M Rainwater; J R Goellner
Journal:  World J Surg       Date:  1990 May-Jun       Impact factor: 3.352

9.  Can CD10 be used as a diagnostic marker in thyroid pathology?

Authors:  Gülçin Yegen; Mehmet Akif Demir; Yeşim Ertan; Olcay Ak Nalbant; Müge Tunçyürek
Journal:  Virchows Arch       Date:  2008-11-25       Impact factor: 4.064

10.  Minimally Invasive Follicular Carcinoma.

Authors:  Maria L. Carcangiu
Journal:  Endocr Pathol       Date:  1997       Impact factor: 3.943

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.